Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00847977
Other study ID # BRD 08/3-J
Secondary ID
Status Terminated
Phase Phase 3
First received February 18, 2009
Last updated January 30, 2013
Start date October 2008
Est. completion date October 2010

Study information

Verified date January 2013
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

isotonic NaCl serum is the first intent solution for infusion during the initial phase of reanimation for an acute cranial traumatism.

However, its use can trigger an hyperchloremic metabolic acidosis, what could be deleterious for the future of this patient.

Isofundine present all charateristics to be use in this indication: pharmacokinetic and pharmacodynamic similar to the physiologic serum, iso-osmolarity to plasma, no glucose provision and no interaction with hemostasis.


Description:

Participation in the study lasts 7 days per patient.

Both solutions are crystalloids who received MA in France for ISOFUNDINE, MA in Germany with pending MA in France for TETRASPAN, including an indication for infusion. Both solutions are consistent with the recommendations of intensive care of a traumatized brain: iso-osmolar and without glucose. The study is an emergency: the resuscitation of a head injury, for which the plasma by crystalloids may be delayed.

J0: Day of Inclusion

On arrival at the emergency operating room at the diagnosis of a serious head injury alone, the anaesthetist that supports the patient in an initial phase includes the patient in the study.

A H0, it is holding the patient randomization and continued his rehabilitation with the lot of fluids allocated. If he wants to use macro-molecules, it may use HydroxyEhtylAmidons(HEA). Each batch assigned to a patient includes a crystalloids and HEA: witnesses arm includes saline solution and the HEAfusine while the interventional arm includes Isofundine and tetraspan. These treatment are indistinguishable and both provided by the laboratory Braun. They will be kept in operating emergency to be the most readily available, upon arrival of the patient. If the health of the patient requires a refill crystalloids emergency even before randomization did not take place, the clinician uses originally Saline and starts the protocol as soon as possible as soon as the patient him can take the few minutes needed to achieve inclusion. The first biological assessment include the determination of natremia, of kaliemia, of magnesemia, the ionized calcium, the lactatemia of albumin, the osmolarity of plasma and blood gases. These strengths are in Biological standard of care of a traumatized brain.

Apart from the contribution of crystalloids, the rest is therapeutic to the discretion of clinicians. The indication of monitoring the intra-cranial pressure sensor intra-parenchymatous is left to the discretion of the clinician without obligation associated with the study. As requires the usual care of this pathology, the patient is then transferred to intensive care.

J1 and J2

In accordance with the Memorandum of service, a basic daily infusion of crystalloids (30 ml / kg / day) is prescribed to all patients during the first 48 hours. The crystalloids used for these basic inputs is the lot assigned at inclusion.

If the indications of plasma referred to by hemodynamic boli solutes remain free indication of the doctor taking care of the patient, type of fluid used is the batch assigned to the patient (Isofundine-Physiologic serum), including the use of macromolecules that are available in the lot assigned to the patient (Heafusine-tetraspan).

Biological monitoring TBI usually based on a biological assessment every 12 hours. It includes a ionograms blood and blood gases. On the same samples without extract a larger volume of blood, we collect specifically in biological assessments:

- ionized calcium, magnesemia, natremia, kaliemia.

- lactatemia.

- albumin.

- plasma osmolarity. No blood gases.

Neurological based monitoring as requested by the clinician is changing the values of either the PIC transcranial doppler.

The contribution of treatment under study stops at the 48th hour, after that time, the inflow of fluid is pursued in accordance with the wishes of doctors, and the type of product is imposed by the study .

J7 or exit resuscitation

The end of the study is the 7th day of inclusion (not trauma), or the day of release resuscitation if it precedes the 7th day. This is the end of the collection of clinical data and biological weapons. From J2-J7, no treatment and no record is imposed by the study. This is a simple monitoring period assessing the future clinical neurological patients.


Recruitment information / eligibility

Status Terminated
Enrollment 42
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Glasgow < or equal to 8

- Patient > 18 years old

Exclusion Criteria:

- Polytraumatism

- Pregnancy

- Patient under guardianship

- renal insufficiency, hypokaliemia, hypocalcemia

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
use of a non balced fluid and of a macromolecular fluid
Physiological serum: basic flow 30 ml/kg/j during 48 hoursand boli wished by physicians 20 ml/kg on 20 minutes Heafusine: boli 10 ml/kg on 20 minutes
use of balanced crystalloids fluid and macromolecular fluid
Isofundine: basic flow 30 ml/kg/j during 48 hoursand boli wished by physicians 20 ml/kg on 20 minutes Tetraspan: boli 10 ml/kg on 20 minutes

Locations

Country Name City State
France Service de Réanimation CHU de Nantes Boulevard Jean Monnet Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of hyperchloremic acidosis during the 2 first days of acute cranial traumatism. J1 and J2 No
Secondary Incidence of hypokaliemia and hypocalcemia J1 and J2 No
Secondary Study of treatment effect on the evolution of intracranil pressure. J1 and J2 No
See also
  Status Clinical Trial Phase
Completed NCT03291964 - Rapid MRI for Acute Pediatric Head Trauma
Completed NCT02828306 - Computer Based Algorithm for Patient Specific Implants for Cranioplasty in Patients With Skull Defects
Completed NCT04505293 - Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas N/A
Not yet recruiting NCT02232347 - Ketamine and Glutamate After Brain Injury : a Microdialysis Study Phase 2
Completed NCT01448473 - Is a Two-Film Skull X-ray Series as Sensitive as a Four-Film Series in the Diagnosis of Skull Fractures in Paediatric Patients N/A
Completed NCT00622778 - Immunemodulation in Patients With Minor Head Injury N/A
Completed NCT04495634 - Evaluation of a Carbon Nanotube Enabled Solid-State Head CT N/A
Terminated NCT03680911 - NAC for Head Trauma-induced Anosmia Phase 3
Recruiting NCT06173427 - Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD
Completed NCT03742427 - Effect of Cervical Collar on the Optic Nerve Sheath Diameter in Minor Head Trauma N/A
Terminated NCT06246500 - Severe Head Trauma: Coagulation and CT-Scan Aggravation.
Withdrawn NCT03453749 - Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury Phase 2
Completed NCT00995683 - Preventive Sodium Lactate and Traumatic Brain Injury Phase 2/Phase 3
Not yet recruiting NCT05195606 - The Effect of Auditory and Tactile Stimuli in Traumatic Coma N/A
Completed NCT04020874 - Reducing Head Impact Exposure in Hawaii High School Football N/A
Not yet recruiting NCT06113939 - Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning N/A
Recruiting NCT05386966 - Medicolegal Aspects of Head Trauma
Not yet recruiting NCT03704272 - Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral N/A
Active, not recruiting NCT00196131 - Problems With Morphine Use in Patients With a Severe Brain Injury Phase 1/Phase 2
Withdrawn NCT02798601 - Early Induced Hypernatremia for the Prevention and Management of Brain Edema N/A